Literature DB >> 24222838

Early discharge after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Awsan Noman1, Azfar G Zaman, Clyde Schechter, Karthik Balasubramaniam, Rajiv Das.   

Abstract

BACKGROUND: To assess safety of early discharge following primary percutaneous coronary intervention (PPCI) for ST-elevation myocardial infarction (STEMI). METHODS AND
RESULTS: Retrospective analysis of prospectively collected data of 2448 STEMI patients treated with PPCI surviving to hospital discharge. Post-discharge all-cause mortality was reported at 1, 7, and 30 days and long-term follow up. A total of 1542 patients (63.0%) were discharged within 2 days of admission (early discharge group) and 906 patients (37.0%) after 2 days (late discharge group). In both groups, no deaths were recorded 1 day post discharge. The early and late discharge group mortality figures for 7 days were 0 and 4 patients (0.04%) and between 7 and 30 days were 11 (0.7%) and 11 patients (1.2%), respectively. During a mean follow up of 584 days, 178 patients (7.3%) died: 67 in the early discharge group (4.3%) and 111 in the late discharge group (12.3%).
CONCLUSIONS: This exploratory, observational study demonstrates that discharging low-risk STEMI patients within 2 days following PPCI is safe. For providers of health care, early discharge can help to allay the cost of providing a 24-hour PPCI service and adds to the recognized benefits arising from PPCI.

Entities:  

Keywords:  Mortality; myocardial infarction; primary angioplasty

Mesh:

Substances:

Year:  2013        PMID: 24222838      PMCID: PMC3821814          DOI: 10.1177/2048872612475231

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  25 in total

1.  Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.

Authors:  Maurits T Dirksen; Eelko Ronner; Gert-Jan Laarman; Loek van Heerebeek; Ton Slagboom; L Ron van der Wieken; Poll A van der Wouw; Ferdinand Kiemeneij
Journal:  J Invasive Cardiol       Date:  2005-10       Impact factor: 2.022

2.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Frederick G Kushner; Mary Hand; Sidney C Smith; Spencer B King; Jeffrey L Anderson; Elliott M Antman; Steven R Bailey; Eric R Bates; James C Blankenship; Donald E Casey; Lee A Green; Judith S Hochman; Alice K Jacobs; Harlan M Krumholz; Douglass A Morrison; Joseph P Ornato; David L Pearle; Eric D Peterson; Michael A Sloan; Patrick L Whitlow; David O Williams
Journal:  Circulation       Date:  2009-11-18       Impact factor: 29.690

3.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.

Authors:  C L Grines; D L Marsalese; B Brodie; J Griffin; B Donohue; C R Costantini; C Balestrini; G Stone; T Wharton; P Esente; M Spain; J Moses; M Nobuyoshi; M Ayres; D Jones; D Mason; D Sachs; L L Grines; W O'Neill
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Anvar Babaev; Paul D Frederick; David J Pasta; Nathan Every; Tina Sichrovsky; Judith S Hochman
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

5.  A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion.

Authors:  E J Topol; K Burek; W W O'Neill; D G Kewman; N H Kander; M J Shea; M A Schork; J Kirscht; J E Juni; B Pitt
Journal:  N Engl J Med       Date:  1988-04-28       Impact factor: 91.245

6.  Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.

Authors:  Ulf Stenestrand; Johan Lindbäck; Lars Wallentin
Journal:  JAMA       Date:  2006-10-11       Impact factor: 56.272

7.  Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction.

Authors:  Laurie Lambert; Kevin Brown; Eli Segal; James Brophy; Josep Rodes-Cabau; Peter Bogaty
Journal:  JAMA       Date:  2010-06-02       Impact factor: 56.272

8.  Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Prague-5".

Authors:  Radovan Jirmár; Petr Widimský; Jan Capek; Ota Hlinomaz; Ladislav Groch
Journal:  Int Heart J       Date:  2008-11       Impact factor: 1.862

9.  Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention?

Authors:  Mark A Kotowycz; Renu Pal Syal; Rizwan Afzal; Madhu K Natarajan
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

10.  Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).

Authors:  Mark A Kotowycz; Tammy L Cosman; Corinne Tartaglia; Rizwan Afzal; Renu Pal Syal; Madhu K Natarajan
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

View more
  8 in total

1.  Almanac 2013: acute coronary syndromes.

Authors:  Pascal Meier; Alexandra J Lansky; Andreas Baumbach
Journal:  Wien Klin Wochenschr       Date:  2014-03       Impact factor: 1.704

2.  Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Authors:  Zain Ul Abideen Asad; Safi U Khan; Amod Amritphale; Adhir Shroff; Kusum Lata; Arnold H Seto; Muhammad Shahzeb Khan; Sunil V Rao; Mazen Abu-Fadel
Journal:  Cardiovasc Revasc Med       Date:  2020-05-01

3.  The impacts of prolonged emergency department length of stay on clinical outcomes of patients with ST-segment elevation myocardial infarction after reperfusion.

Authors:  Huang-Chung Chen; Wei-Chieh Lee; Yung-Lung Chen; Hsiu-Yu Fang; Chien-Jen Chen; Cheng-Hsu Yang; Chi-Ling Hang; Chih-Yuan Fang; Hon-Kan Yip; Chiung-Jen Wu
Journal:  Intern Emerg Med       Date:  2015-10-26       Impact factor: 3.397

Review 4.  What is new in the 2017 ESC clinical practice guidelines : Management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Irene M Lang
Journal:  Wien Klin Wochenschr       Date:  2018-05-23       Impact factor: 1.704

5.  Acute myocardial infarction hospital admissions and deaths in England: a national follow-back and follow-forward record-linkage study.

Authors:  Perviz Asaria; Paul Elliott; Margaret Douglass; Ziad Obermeyer; Michael Soljak; Azeem Majeed; Majid Ezzati
Journal:  Lancet Public Health       Date:  2017-03-01

6.  Safety and Feasibility of 48 h Discharge After Successful Primary Percutaneous Coronary Intervention.

Authors:  Nooraldaem Yousif; Tarique S Chachar; Suddharsan Subbramaniyam; Vinayak Vadgaonkar; Husam A Noor
Journal:  J Saudi Heart Assoc       Date:  2021-04-19

7.  The CADILLAC risk score accurately identifies patients at low risk for in-hospital mortality and adverse cardiovascular events following ST elevation myocardial infarction.

Authors:  Ryan S Wilson; Peter Malamas; Brent Dembo; Sumeet K Lall; Ninad Zaman; Brandon R Peterson
Journal:  BMC Cardiovasc Disord       Date:  2021-11-12       Impact factor: 2.298

8.  NT-proBNP during and after primary PCI for improved scheduling of early hospital discharge.

Authors:  D A A M Schellings; A W J van 't Hof; J M Ten Berg; A Elvan; E Giannitsis; C Hamm; H Suryapranata; A Adiyaman
Journal:  Neth Heart J       Date:  2017-04       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.